Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP895745.RAHPSZIjW49oV7Sw7BOtu_EDH-XoUJbRHToWKIHXynLHU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP895745.RAHPSZIjW49oV7Sw7BOtu_EDH-XoUJbRHToWKIHXynLHU130_assertion type Assertion NP895745.RAHPSZIjW49oV7Sw7BOtu_EDH-XoUJbRHToWKIHXynLHU130_head.
- NP895745.RAHPSZIjW49oV7Sw7BOtu_EDH-XoUJbRHToWKIHXynLHU130_assertion description "[ChoK? specific inhibitors, MN58b and TCD-717, have demonstrated a potent antitumoral activity both in vitro and in vivo against several tumor-derived cell line xenografts including CRC-derived cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP895745.RAHPSZIjW49oV7Sw7BOtu_EDH-XoUJbRHToWKIHXynLHU130_provenance.
- NP895745.RAHPSZIjW49oV7Sw7BOtu_EDH-XoUJbRHToWKIHXynLHU130_assertion evidence source_evidence_literature NP895745.RAHPSZIjW49oV7Sw7BOtu_EDH-XoUJbRHToWKIHXynLHU130_provenance.
- NP895745.RAHPSZIjW49oV7Sw7BOtu_EDH-XoUJbRHToWKIHXynLHU130_assertion SIO_000772 23762272 NP895745.RAHPSZIjW49oV7Sw7BOtu_EDH-XoUJbRHToWKIHXynLHU130_provenance.
- NP895745.RAHPSZIjW49oV7Sw7BOtu_EDH-XoUJbRHToWKIHXynLHU130_assertion wasDerivedFrom befree-20140225 NP895745.RAHPSZIjW49oV7Sw7BOtu_EDH-XoUJbRHToWKIHXynLHU130_provenance.
- NP895745.RAHPSZIjW49oV7Sw7BOtu_EDH-XoUJbRHToWKIHXynLHU130_assertion wasGeneratedBy ECO_0000203 NP895745.RAHPSZIjW49oV7Sw7BOtu_EDH-XoUJbRHToWKIHXynLHU130_provenance.